Here are the latest quarterly results of COHANCE LIFESCIENCES. For more details, see the COHANCE LIFESCIENCES financial fact sheet and COHANCE LIFESCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
| No. of Mths Qtr. Ending |
3
Sep-24* |
3
Dec-24* |
3
Mar-25* |
3
Jun-25* |
3
Sep-25* |
3
Dec-25* |
3
Mar-26* |
3
Jun-26* |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 6,038 | 6,762 | 8,404 | 5,493 | 5,556 | 5,446 | 6,191 | 4,223 | |
| Other income | Rs m | 162 | 216 | 121 | 142 | 156 | 62 | -18 | 123 | |
| Turnover | Rs m | 6,200 | 6,978 | 8,525 | 5,635 | 5,712 | 5,507 | 6,173 | 4,345 | |
| Expenses | Rs m | 3,984 | 4,389 | 6,112 | 4,373 | 4,346 | 4,492 | 5,204 | 4,211 | |
| Gross profit | Rs m | 2,054 | 2,374 | 2,134 | 1,039 | 1,210 | 905 | 822 | 12 | |
| Depreciation | Rs m | 378 | 436 | 542 | 451 | 440 | 469 | 512 | 495 | |
| Interest | Rs m | 96 | 108 | 105 | 102 | 88 | 91 | 92 | 67 | |
| Profit before tax | Rs m | 1,742 | 2,046 | 1,609 | 628 | 838 | 406 | 199 | -429 | |
| Tax | Rs m | 359 | 511 | 437 | 164 | 174 | 116 | 116 | 23 | |
| Profit after tax | Rs m | 1,382 | 1,535 | 1,172 | 464 | 664 | 290 | 83 | -452 | |
| Gross profit margin | % | 34.0 | 35.1 | 25.4 | 18.9 | 21.8 | 16.6 | 13.3 | 0.3 | |
| Effective tax rate | % | 20.6 | 25.0 | 27.2 | 26.1 | 20.7 | 28.5 | 58.3 | -5.4 | |
| Net profit margin | % | 22.9 | 22.7 | 13.9 | 8.4 | 11.9 | 5.3 | 1.3 | -10.7 | |
| Diluted EPS | Rs | 3.6 | 4.0 | 3.1 | 1.2 | 1.7 | 0.8 | 0.2 | -1.2 | |
| Diluted EPS (TTM) | Rs | 8.2 | 11.0 | 12.7 | 11.9 | 10.0 | 6.8 | 3.9 | 1.5 | |
Although the benchmark indices opened lower, they traded negative throughout the session and ultimately closed red.